Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603102's ROE % is ranked better than 52.18% of 1924
companies
in the Consumer Packaged Goods industry
Industry Median: 6.805
vs SHSE:603102: 7.38
Weihai Baihe Biology Technological Co (SHSE:603102) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Weihai Baihe Biology Technological Co ROE % Related Terms
Weihai Baihe Biology Technological Co ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Weihai Baihe Biology Technological Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Weihai Baihe Biology Technological Co ROE % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Weihai Baihe Biology Technological Co's ROE % distribution charts can be found below:
* The bar in red indicates where Weihai Baihe Biology Technological Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Weihai Baihe Biology Technological Co (SHSE:603102) has a ROE % of 6.93% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Weihai Baihe Biology Technological Co and its competitors. This is 64% below median its historical median of 19.46. Over the past decade, Weihai Baihe Biology Technological Co's ROE % has ranged from 7.38 to 24.39. According to the industry distribution chart, Weihai Baihe Biology Technological Co ranks #920 out of 1924 companies in the Consumer Packaged Goods industry, placing it in the top 47.8%.
Is Weihai Baihe Biology Technological Co's ROE % too high?
Weihai Baihe Biology Technological Co's current ROE % of 6.93% is 64% below median its 10-year median of 19.46. Over the past 10 years, this metric has ranged from a low of 7.38 to a high of 24.39. The Consumer Packaged Goods industry median ROE % is 6.81. Weihai Baihe Biology Technological Co's value of 6.93% is 1.8% above this industry median. Based on the distribution chart, Weihai Baihe Biology Technological Co ranks #920 out of 1924 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Weihai Baihe Biology Technological Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Weihai Baihe Biology Technological Co's ROE % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Weihai Baihe Biology Technological Co ranks #920 out of 1924 companies for ROE %. This puts Weihai Baihe Biology Technological Co in the upper half of its industry. The industry median ROE % is 6.81. Weihai Baihe Biology Technological Co's value of 6.93% is 1.8% above this benchmark. Historically, Weihai Baihe Biology Technological Co's own ROE % has ranged from 7.38 to 24.39 over the past decade. While the company's 10-year median is 19.46 vs. the industry median of 6.81, Weihai Baihe Biology Technological Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.81, based on 1,924 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Weihai Baihe Biology Technological Co's current ROE % of 6.93% is 1.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Weihai Baihe Biology Technological Co and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Weihai Baihe Biology Technological Co's current ROE % is 6.93%, which is 64% below median its own 10-year median of 19.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weihai Baihe Biology Technological Co stock overvalued right now?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co (SHSE:603102) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥48.82, compared to a current price of ¥31.85 — trading 34.8% below its estimated fair value. The current ROE % is 6.93%, which is 64% below median its 10-year median of 19.46 and 1.8% above the Consumer Packaged Goods industry median of 6.81. Weihai Baihe Biology Technological Co's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Weihai Baihe Biology Technological Co (SHSE:603102), the current ROE % is 6.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Weihai Baihe Biology Technological Co (SHSE:603102) Overvalued in 2026?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co stock appears to be undervalued.
The current stock price of ¥31.85 is trading 34.8% below its estimated GF Value™ of ¥48.82.
GuruFocus considers Weihai Baihe Biology Technological Co to be Significantly Undervalued.
Key valuation signals for SHSE:603102:
ROE %: 6.93% (64% below median its 10-year median of 19.46)
GF Value™: ¥48.82 vs. price of ¥31.85 (34.8% below fair value)
Industry Position: 1.8% above the Consumer Packaged Goods median (#920 of 1924)
No single metric tells the full story. See the SHSE:603102 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Weihai Baihe Biology Technological Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603102 has been successfully added to your 
